F. Hoffmann-La Roche Ltd (batch release; secondary packaging)

Ukraine

All drugs from this manufacturer

  • GAZIVA

    The drug is used for the treatment of adults with chronic lymphocytic leukemia (in combination with chlorambucil), as well as for the treatment of patients with follicular lymphoma (both in combination with chemotherapy and as maintenance therapy).

    Dosage form: concentrate for infusion solution

    Active substance Dosage
    obinutuzumab 25 mg/ml

    ATC: L01FA03